Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

LA JOLLA PHARMACEUTICAL CO (LJPC)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21Dec-31-20Sep-30-20
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Operating activities          
Net income  4.05.219.712.42.9-16.4-39.4-61.2
   
Adjustments to reconcile net income to net cash from operating activities:          
    Non-cash interest expense  6.26.97.16.66.76.46.47.1
    Share-based compensation expense  5.04.64.54.14.44.96.29.6
    Amortization of intangible assets  1.61.61.61.61.41.00.60.3
    Amortization of right-of-use lease assets  0.20.20.20.30.71.01.21.4
    Depreciation expense  0.10.10.10.10.41.22.23.3
    Gain on forgiveness of Paycheck Protection Program loan   -2.3      
    Gain on sale of non-controlling equity interest   -0.7      
    (Gain) loss on change in fair value of contingent value rights  -0.1-0.2  0.40.5  
    Loss on foreign currency exchange  0.4       
    Inventory fair value step-up adjustment included in cost of product sales       3.32.51.2
    Changes in operating assets and liabilities:          
        Accounts receivable, net  2.7-1.6-2.8-4.9-5.60.6-1.7-1.3
        Inventory, net  -2.8-1.7-1.1-0.9-0.9-2.0-1.5-1.8
        Prepaid expenses and other current assets  1.30.6-2.4-1.0-1.2-1.52.32.8
        Accounts payable  -4.0-3.6-4.1-4.9-6.3-5.4-14.2-6.8
        Accrued expenses and other current liabilities  -5.3-6.2-4.5-5.4-6.8-7.9-11.4-5.1
        Lease liabilities  -0.2-0.2-0.2-0.3-0.9-1.5-2.1-2.6
            Net cash provided by operating activities  13.113.628.217.87.3-8.2-37.6-47.5
   
Investing activities          
    Net cash provided by investing activities  0.3  0.0   -31.0
   
Financing activities          
Purchases of common stock under stock repurchase plan  -11.4-8.6-3.4     
Net proceeds from issuance of common stock under ESPP  0.50.50.40.40.40.40.50.6
Net proceeds from issuance of common stock under 2013 Equity Plan     0.20.20.5  
    Net cash (used for) provided by financing activities  -10.9-8.0-2.80.60.50.81.11.2
   
Supplemental disclosure of non-cash investing and financing activities          
Forgiveness of Paycheck Protection Program loan   2.3      
Sale of non-controlling equity interest   0.7      
   
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets          
Cash and cash equivalents          
Restricted cash          

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy